Application of high-throughput sequencing technology to analyze the association of GDM maternal weight gain during pregnancy with the characteristics of neonatal gut microbiota

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050968

Enrollment

Unknown

Registered

2021-09-08

Start date

2021-08-31

Completion date

Unknown

Last updated

2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus (GDM)

Interventions

Neonatal group of gestational diabetes mellitus delivered by normal pregnant women with gestational weight gain:None

Neonatal group delivered by pregnant women with excess weight gain with gestational diabetes mellitus:None

Healthy control group:None

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Full-term singleton, vaginal delivery; 2. Regular obstetric inspection and complete clinical information; 3. Not taking drugs that affect glucose metabolism during pregnancy; 4. Not taking antibiotics within 2 weeks before delivery.

Exclusion criteria

Exclusion criteria: 1. Gastrointestinal or reproductive tract infection occurred before childbirth; 2. Combined with serious medical and surgical diseases; 3. Birth defects of the fetus; 4. The neonates had used antibiotics before meconium was collected.

Design outcomes

Primary

Measure	Time frame
Weight gain during pregnancy;	—

Countries

China

Contacts

Public ContactZhang Xueqin

Wind459@126.com+86 592 2662041

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026